Strategic Partnership Saladax recently announced a distribution agreement with Thermo Fisher Scientific to expand global access to high-quality therapeutic drug monitoring (TDM) assays, presenting a ready-made channel for co-selling and broader market penetration.

Regulatory Growth New leadership in regulatory and quality (Director appointed) indicates a focus on compliance and scalable quality systems, enabling smoother entry into regulated markets and potential collaboration on clinical trial approvals and companion diagnostics.

Regional Expansion Appointment of a DACH country manager signals targeted expansion in Germany, Austria, and Switzerland, suggesting opportunities to partner with regional distributors, labs, and hospitals seeking TDM assays for psychiatry and oncology.

Acquired IP Assets Acquisition of Janssen’s antipsychotic drug testing IP creates a defensible technology moat and potential upsell of enhanced assays to existing customers, as well as cross-sell with pharmaceutical partners expanding trial programs.

Clinical Trial Readiness Active collaboration with pharmaceutical companies for tests in clinical trials and companion diagnostics points to opportunities to offer end-to-end TDM solutions for trial sponsors, CROs, and contract labs seeking validated assay platforms.